Retrospective review of healthcare costs associated with treatment-resistant depression (TRD) in Italy CONTEXT: Published in the ClinicoEconomics and Outcomes Research Journal, this retrospective review of around 6 million administrative database Continue Reading
CONTEXT: Continuing this years theme of presenting RWR posters alongside traditional RCTs, Teva showed off their AJOVY (fremanezumab-vfrm) treatment for migraine at the American Headache Society annual meeting. Also included Continue Reading
CONTEXT: An interview article with a UK based company looking to bring “natural” psilocybin medicines to market through RWE studies and dodge the usual RCT regulatory routes. One to watch Continue Reading
CONTEXT: A little off our usual remit of RWR, but we think this kind of advancement in mental health warrants putting on our news site. Being able to use a Continue Reading
